Published in J Infect Dis on December 01, 1993
Correlation between circulating HIV-1 RNA and broad HIV-1 neutralizing antibody activity. J Acquir Immune Defic Syndr (2011) 0.88
Serologic evaluation of human immunodeficiency virus type 1-infected individuals from Argentina and the United States indicates a similar distribution of subgroup B isolates. J Clin Microbiol (1995) 0.87
Anti-V3 antibody reactivity correlates with clinical stage of HIV-1 infection and with serum neutralizing activity. Clin Exp Immunol (1995) 0.77
Human immunodeficiency virus type 1 disease progression, CCR5 genotype, and specific immune responses. Clin Diagn Lab Immunol (1998) 0.76
The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study. BMC Infect Dis (2017) 0.75
Presence of neutralizing antibodies to heterologous human immunodeficiency virus type 1 isolates in sera of infected individuals is not predictive of rate of disease progression. Clin Diagn Lab Immunol (1995) 0.75
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science (1990) 6.77
Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins. J Virol (1987) 5.03
Induction of nuclear transport with a synthetic peptide homologous to the SV40 T antigen transport signal. Cell (1986) 4.56
Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J (1986) 4.32
Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest (1989) 3.92
Relapsing illness due to Rochalimaea henselae in immunocompetent hosts: implication for therapy and new epidemiological associations. Clin Infect Dis (1992) 3.61
Natural infection of Suffolk sheep with scrapie virus. J Infect Dis (1982) 3.42
Pathogenesis of scrapie virus infection in the mouse. J Infect Dis (1967) 3.34
Origin and molecular specification of striatal interneurons. J Neurosci (2000) 3.24
Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci U S A (1999) 3.21
Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest (1993) 3.19
Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest (1994) 3.12
Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother (2004) 3.09
Aleutian disease of mink: properties of the etiologic agent and the host responses. J Infect Dis (1968) 3.03
Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol (1990) 2.99
Bartonella henselae neuroretinitis in cat scratch disease. Diagnosis, management, and sequelae. Ophthalmology (1998) 2.43
Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci U S A (2001) 2.35
Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science (1993) 2.35
Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science (1986) 2.33
Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J Immunol (1991) 2.17
Nosocomial Legionnaires' disease: aspiration as a primary mode of disease acquisition. Am J Med (1993) 2.08
Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide. Virology (1988) 2.05
Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med (1998) 2.01
Probenecid and zidovudine metabolism. Lancet (1989) 1.99
Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis (1995) 1.97
Molecular genotyping of methicillin-resistant Staphylococcus aureus via fluorophore-enhanced repetitive-sequence PCR. J Clin Microbiol (1995) 1.92
Virologic and neurohistologic findings in dairy goats affected with natural scrapie. Vet Pathol (1980) 1.88
Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature (1989) 1.80
Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients. Ann Intern Med (1993) 1.79
Comparative pathogenicity of four strains of Aleutian disease virus for pastel and sapphire mink. Infect Immun (1983) 1.77
Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. J Clin Invest (1989) 1.77
Characterization of PEDF: a multi-functional serpin family protein. J Cell Biochem (2009) 1.77
A close look at alcohol gel as an antimicrobial sanitizing agent. Am J Infect Control (1999) 1.71
In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis (1995) 1.69
DLX-1, DLX-2, and DLX-5 expression define distinct stages of basal forebrain differentiation. J Comp Neurol (1999) 1.68
Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg (2001) 1.63
Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg (2001) 1.60
Legionnaires' disease in human immunodeficiency virus-infected patients: eight cases and review. Clin Infect Dis (1994) 1.59
Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. Mol Pharmacol (1992) 1.57
False-positive rapid plasma reagin tests in human immunodeficiency virus infection and relationship to anti-cardiolipin antibody and serum immunoglobulin levels. J Infect Dis (1994) 1.57
Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci U S A (1994) 1.53
Methods for magnetically labeling stem and other cells for detection by in vivo magnetic resonance imaging. Cytotherapy (2004) 1.52
Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection. Cell Microbiol (2000) 1.49
Immune response to hepatitis B surface antigen: enhancement by prior injection of antibodies to the idiotype. Science (1983) 1.48
Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection. Antimicrob Agents Chemother (1991) 1.48
Isolation of a virus from the lungs of Montana sheep affected with progressive pneumonia. Virology (1968) 1.46
Pneumonia associated with near-drowning. Clin Infect Dis (1997) 1.42
Cytomegalovirus polyradiculopathy in HIV-infected patients. J Gen Intern Med (1996) 1.41
Obstetric fistula in rural Ethiopia. East Afr Med J (2007) 1.38
Development of specific fluorescent-antibody test for tissue form of Penicillium marneffei. J Clin Microbiol (1995) 1.38
Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus. J Infect Dis (2001) 1.38
Common idiotypic determinant associated with human antibodies to hepatitis B surface antigen. J Immunol (1983) 1.38
Course of experimental scrapie virus infection in the goat. J Infect Dis (1974) 1.36
Novel role of phosphorylation in Fe-S cluster stability revealed by phosphomimetic mutations at Ser-138 of iron regulatory protein 1. Proc Natl Acad Sci U S A (1998) 1.36
Biotin-avidin-amplified enzyme immunoassay for detection of herpes simplex virus antigen in clinical specimens. J Clin Microbiol (1983) 1.36
Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J Infect Dis (1996) 1.36
Enhancement of the immune response to hepatitis B surface antigen. In vivo administration of antiidiotype induces anti-HBs that expresses a similar idiotype. J Exp Med (1984) 1.35
Iron-responsive element-binding protein. Phosphorylation by protein kinase C. J Biol Chem (1993) 1.34
Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis. J Infect Dis (1992) 1.30
Isolation and characterization of simian immunodeficiency viruses from two subspecies of African green monkeys. AIDS Res Hum Retroviruses (1990) 1.29
Neuroretinitis, aseptic meningitis, and lymphadenitis associated with Bartonella (Rochalimaea) henselae infection in immunocompetent patients and patients infected with human immunodeficiency virus type 1. Clin Infect Dis (1995) 1.29
Total lymphocyte count as a predictor of absolute CD4+ count and CD4+ percentage in HIV-infected persons. JAMA (1993) 1.27
Relation of the Escherichia coli dnaX gene to its two products--the tau and gamma subunits of DNA polymerase III holoenzyme. Nucleic Acids Res (1987) 1.25
A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein. Infect Immun (1994) 1.24
Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees. Science (1986) 1.24
Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection. J Immunol (1999) 1.23
The gene for HMSN2C maps to 12q23-24: a region of neuromuscular disorders. Neurology (2003) 1.22
Patterns of virus burden and T cell phenotype are established early and are correlated with the rate of disease progression in human immunodeficiency virus type 1-infected persons. J Infect Dis (1996) 1.22
Comparison and characterization of immunoglobulin G subclasses among primate species. Clin Diagn Lab Immunol (1999) 1.21
Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol (1988) 1.21
Pax-6 regulates expression of SFRP-2 and Wnt-7b in the developing CNS. J Neurosci (2001) 1.18
Application of a modified computer algorithm in determining potential antigenic determinants associated with the AIDS virus glycoprotein. Anal Biochem (1985) 1.15
Guidelines for the methodology of exercise challenge testing of asthmatics. Study Group on Exercise Challenge, Bronchoprovocation Committee, American Academy of Allergy. J Allergy Clin Immunol (1979) 1.15
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: further clarifications. Science (1991) 1.14
Dextran sulfate is poorly absorbed after oral administration. Ann Intern Med (1989) 1.13
Demonstration, by immunoelectronmicroscopy, of a cell wall antigen in Trichosporon beigelii that cross-reacts with Cryptococcus neoformans capsular polysaccharide. J Infect Dis (1988) 1.13
Significant infections due to Bacillus species following abrasions associated with motor vehicle-related trauma. Clin Infect Dis (1992) 1.12
The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6) Id and anti-polynucleotide activity. Clin Exp Immunol (1987) 1.12
Anti-human immunodeficiency virus (HIV) activity, safety, and pharmacokinetics of adefovir dipivoxil (9-[2-(bis-pivaloyloxymethyl)-phosphonylmethoxyethyl]adenine) in HIV-infected patients. J Infect Dis (1997) 1.12
Induction of an anti-hepatitis B surface antigen response in mice by noninternal image (Ab2 alpha) anti-idiotypic antibodies. J Immunol (1987) 1.11
Coccidioidomycosis: a persistent threat to deployed populations. Aviat Space Environ Med (1993) 1.11
Regulation of capsule gene expression by group A Streptococcus during pharyngeal colonization and invasive infection. Mol Microbiol (2001) 1.10
Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin. AIDS (1996) 1.09